Aranthan Jones II, Chief Corporate Affairs Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 7,200 shares at $11.81 ($85K) on 2020-08-12, disclosed to the SEC on 2020-08-14.
Open-market sale of $85k VNDA by Chief Corporate Affairs Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VNDA | SELL | 2021-03-16 | $319K | — | Filing → |
| VNDA | SELL | 2021-03-03 | $139K | — | Filing → |
| VNDA | SELL | 2021-02-26 | $920K | — | Filing → |